期刊文献+

粒细胞集落刺激因子在化疗患者中的应用调查 被引量:10

暂未订购
导出
摘要 目的调查本院恶性肿瘤化疗患者使用粒细胞集落刺激因子(granulocyte colony-stimulating factor,G-CSF)的状况,以评估临床肿瘤学专业医师对G-CSF使用的规范性。方法对2012年6月至2013年6月在本院肿瘤内科接受化疗的恶性实体瘤和淋巴瘤住院患者进行调查,记录个人信息、化疗情况及使用G-CSF的情况,参照G-CSF使用指南,评估其使用的合理性。结果对171例化疗患者980次化疗进行调查,其中预防性使用G-CSF中,有129次使用与指南推荐相符(规范使用),有14次使用指南未推荐(使用过度)。181次有使用指征而未预防性使用(使用不足)。在治疗性使用G-CSF中,有高达428次(43.7%)的使用属于使用过度。结论目前本院绝大部分患者的G-CSF使用与指南推荐不符,临床实践与指南推荐之间存在较大差异。临床肿瘤学专业医师要提高对G-CSF使用规范的认识,以促进G-CSF的规范、合理使用。
作者 顾玉兰
出处 《中国癌症防治杂志》 CAS 2014年第2期177-180,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
  • 相关文献

参考文献16

  • 1Smith TJ,Khatcheressian J,Lyman GH,et al.2006 update of rec-ommendations for the use of white blood cell growth factors:an evi-dencebased clinical practice guideline[J].J Clin Oncol,2006,24(19):3187-3205.
  • 2Myeloid growth factors[EB/OL].[2013-01].http://www.nccn.org/pro-fessionals/physician_gls/pdf/myeloid_growth.pdf.
  • 3Kuderer NM,Dale DC,Crawford J,et al.Mortality,morbidity,and costassociated with febrile neutropenia in adult cancer patients[J].Can-cer,2006,106(10):2258-2266.
  • 4Lal A,Bhurgri Y,Rizvi N,et al.Factors influencing in-hospital lengthof stay and mortality in cancer patients suffering from febrile neu-tropenia[J].Asian Pac J Cancer Prev,2008,9(2):303-308.
  • 5Osmani AH,Ansari TZ,Masood N,et al.Outcome of febrile neu-tropenic patients on granulocyte colony stimulating factor in a ter-tiarycare hospital[J].Asian Pac J Cancer Prev,2012,13(6):2523-2526.
  • 6Silvestris N,Del Re M,Azzariti A,et al.Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients:from biologi-cal principles to clinical guidelines[J].Expert Opin Ther Targets,2012,16 Suppl 2:S111-S117.
  • 7Bohlius J,Herbst C,Reiser M,et al.Granulopoiesis-stimulating fac -tors to prevent adverse effects in the treatment of malignant lymphoma[J].Cochrane Database Syst Rev,2008,8(4):CD003189.
  • 8Iwata Y,Fujimoto Y,Morino T,et al.Effects of stem cell mobiliza -tionbygranulocyte colony-stimulating factor on endothelial fuction af-ter sirolimus-eluting stent implantation:a double-blind,randomizdplacebo-controlled clinical tria[J].Am Heart J,2013,165(3):408-414.
  • 9Okazaki T,Ebihara S,Asada M,et al.Granulocyte colony-stimulatingfactor promotes tumor angiogenesis via increasing circulating endothe-lial progenitor cells and Gr1+ CD11b+ cells in cancer animal models[J].Int Immunol,2006,18(1):1-9.
  • 10Shirakawa H,Kikuchi E,Mikami S,et al.Three cases of granulocytecolony-stimulating factor-producing urinary upper tract carcinomas[J].Scand J Urol Nephrol,2012,46(2):136-141.

二级参考文献54

  • 1杨小冬,刘福坤,许哲,陈彻,吴晓宇,李刚,黎介寿.G-CSF受体及其mRNA在结直肠癌和其附近正常黏膜中的表达[J].解放军医学杂志,2005,30(2):149-152. 被引量:6
  • 2阎嶂松,李大鹏,姜尔烈,周春林,冯四洲,陈辉树,李忠廉,韩明哲.经粒细胞集落刺激因子动员的正常供者自发性脾破裂一例——附文献复习[J].中华血液学杂志,2006,27(12):829-832. 被引量:8
  • 3无,孙婉玲(整理者),田丁(整理者).应用重组人粒细胞集落刺激因子的经验与教训专题讨论[J].白血病.淋巴瘤,2007,16(1):1-5. 被引量:8
  • 4Nies BA,Kundel DW,Thomas LB,et al.Leukeponia bone pain and bone necrosis in patients with acute leukemia.Ann Intern Med 1965;62:698-705.
  • 5Cesaro S,Marson P,Gazzola MV,et al.The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.Haematologica,2002,87 (8 Suppl):35-41.
  • 6Becker PS,Wagle M,Matous S,et al.Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (GCSF):occurrence in an allogcncic donor of peripheral blood stem cells.Biol Blood Marrow Transplant,1997,3:45-49.
  • 7Falzetti F,Avcrsa F,Minelli O,et al.Spontaneous rupture of the spleen during peripheral blood stcm-cell mobilization in a healthy donor.Lancet,1999,353:555.
  • 8Balagucr H,Galmes A,Ventayol G,et al.Splenic rupture aftcr granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor.Transfusion,2004,44:1260-1261.
  • 9Dincer AP,Cottschall J,Margolis DA.Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.J Pediatr Hematol Oncol,2004,26:761-763.
  • 10Champlin RE,Schmitz N,Horowitz MM,et al.Blood stem cells compared with bone marrow as a source of hematopoictic cells for allogeneic transplantation.IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).Blood,2000,95:3702-3709.

共引文献28

同被引文献116

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部